First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

1. Carrato, A.
2. Abad, A.
3. Massuti, B.
4. Grávalos, C.
5. Escudero, P.
6. Longo-Muñoz, F.
7. Manzano, J.-L.
8. Gómez, A.
9. Safont, M.J.
10. Gallego, J.
11. García-Paredes, B.
12. Pericay, C.
13. Dueñas, R.
14. Rivera, F.
15. Losa, F.
16. Valladares-Ayerbes, M.
17. González, E.
18. Aranda, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.EJCA.2017.04.024 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus